Masters of Longevity - The Pulse

Fight Aging!01 Jun 2026
Nanomaterial Approaches to Therapy for Osteoarthritis (Fight Aging!)

Nanomaterial Approaches to Therapy for Osteoarthritis

How engineered nanomaterials are being developed to target the joint microenvironment and enable disease-modifying osteoarthritis therapies.

Key takeaways
  • Simple practices can make some difference, such as exercise or calorie restriction.
  • But over the long haul all that really matters is progress in medicine.
  • Sooner these treatments arrive, the more lives will be saved.
Longevity Technology01 Jun 2026
Rebuilding the liver moves toward reality at EASL 2026 (Longevity Technology)

Rebuilding the liver moves toward reality at EASL 2026

Regenerative liver research takes a hopeful turn in this conference roundup, exploring translational advances, experimental techniques and debates shaping future clinical possibilities.

Key takeaways
  • WHO formally recognized liver disease as a global health priority.
  • Max Planck team developed liver organoids that model biliary fibrosis scarring.
  • Engineered bile ducts used pig scaffolds with localized sirolimus release to reduce fibrosis.
Science Daily - Health & Medicine01 Jun 2026
The forgotten organ that could predict how long you live (Science Daily - Health & Medicine)

The forgotten organ that could predict how long you live

The adult thymus takes center stage in this feature exploring new studies, expert commentary, and what the organ might mean for future health research.

Key takeaways
  • Thymic health also predicted better immunotherapy outcomes in patients with cancer.
  • AI analysis of CT scans in tens of thousands linked healthier adult thymuses to longer survival.
  • Healthier thymuses were associated with substantially lower heart disease and cancer risk.
Fight Aging!01 Jun 2026
AIYet Another Proposed Definition for Allostatic Load (Fight Aging!)

Yet Another Proposed Definition for Allostatic Load

A look at a new proteomics-based definition of allostatic load and its reported predictive advantages over traditional biomarker panels.

Key takeaways
  • ProAL50 was constructed from 50 circulating proteins using UK Biobank plasma proteomics.
  • Validation in CARDIA showed stronger prediction of cancer, diabetes, heart disease, lung and kidney disease.
  • Protein signals primarily mapped to lipid metabolic and immune-inflammatory biological pathways.